Crossmark

Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT

Crossref DOI link: https://doi.org/10.1038/s41375-021-01135-2

Published Online: 2021-02-04

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Esteve, Jordi https://orcid.org/0000-0002-8056-648X
Giebel, Sebastian

Labopin, Myriam

Czerw, Tomasz

Wu, Depei

Volin, Liisa

Socié, Gerard

Yakoub-Agha, Ibrahim https://orcid.org/0000-0003-4524-8782
Maertens, Johan

Cornelissen, Jan J.

Pigneux, Arnaud

Shimoni, Avichai https://orcid.org/0000-0001-8782-6160
Schwerdtfeger, Rainer

Labussière-Wallet, Hélène

Russell, Nigel

Schattenberg, Anton

Chevallier, Patrice

Koza, Vladimir

Foà, Robin https://orcid.org/0000-0002-5021-3026
Schmid, Christoph

Peric, Zinaida

Mohty, Mohamad

Nagler, Arnon
License Information

Text and Data Mining valid from 2021-02-04

Version of Record valid from 2021-02-04
More Information

Article History

Received: 21 May 2020

Revised: 9 December 2020

Accepted: 11 January 2021

First Online: 4 February 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below